Dec 10, 2020 06:43 AM EST
A new oral drug, Monulparivir, completely suppresses COVID-19 transmission within 24 hours, according to a study published in the journal of Nature Microbiology.
The team of researchers tested the new oral drug's ability to inhibit the coronavirus spread in ferrets. Dr. Robert Cox, a postdoctoral fellow at Georgia State and a co-lead author, said they believed that ferrets are a relevant transmission model as they could also spread SARS-CoV-2. However, most of the ferrets did not develop severe disease, which more likely resembles COVID-19 spread in young adults.
Daily Mail reported that six ferrets were infected with COVID-19 by the researchers and treated three of the ferrets with Monulparivir when they started shedding the virus from their noses. The team then took 12 uninfected ferrets and two each housed in a cage with one infected animal.
Every day, the ferrets were tested for eight days, and none of them in the cages with treated animals contracted the coronavirus. But on day four, all of the ferrets caged with those not treated by the new oral drug became sick.
Read also: FDA Grants Priority Tag to Pfizer Pneumococcal Vaccine, Company Could Gain Billions in Revenue
With the cases continuing to surge across the United States, stopping the community transmission of the COVID-19 will be the key to curb the pandemic until COVID-19 vaccines become widely available.
Dr. Richard Plemper, a professor at the Institute for Biomedical Sciences at Georgia State, noted that Monulparivir has broad-spectrum activity in fighting respiratory RNA viruses as well as treating infected animals through the oral drug that lowers the amount of shed viral particles, dramatically reducing the transmission.
He added that "these properties made the new oral drug a powerful candidate for pharmacologic control of COVID-19."
The new oral medication prevents the virus from multiplying itself, preventing it from spreading throughout the body. The drug blocked ferrets infected with the coronavirus from transmitting the disease to other animals, but those were not given the medication to spread the disease, researchers found.
The Georgia State University team of researchers claim that COVID-19 patients given with Monulparivir could be non-infectious within a day if the data is translated to humans. "This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission," said Dr. Plemper.
The drug innovation company Emory University in Atlanta discovered the oral antiviral drug, Monulparivir. Initially, the new oral medication was meant to cure influenza and prevent the virus from making copies by creating errors during viral RNA replication. Monulparivir can prevent and decrease severe lung damage in mice infected with COVID-19, as per the April 2020 study.
The new oral drug is now in phase II/II trials, wherein it is tested at three various doses every 12 hours within five days in COVID-19 human patients. However, the data is not expected to be ready until at least May 2021.
Read also: Monulparivir: New Antiviral Drug That Completely Suppresses the Transmission of the COVID-19 in 24 Hours
And the world of NFTs expands far beyond art and collectibles. A new era of tokenized digital assets is being created using the blockchain. Here are seven unique NFT use cases that the interested investor should know.
However, there are some simple steps that anyone can take which will help to improve their performance when it comes to trading foreign exchange markets. Here are ten small things that can make a big difference in your FX trading success.
o prevent significant losses, risk management expertise is essential. His adage, "Rule No. 1: Never lose money," has become a stock market classic. Never forget Rule No. 1; this is Rule No. 2. This practice is followed by even the most successful investor, Warren Buffett, who advises others to follow suit.
One of the significant advancements is shifting the payment operations for remote workers. If the compliances are not met, it may lead to severe legal complications. The owner and organization may be held labially separately. The remote working lifestyle continuously grows and is a testament to becoming an endless working mode. Today we discuss components for payroll for remote workers
BRG International Founder Matias Alem had recognized this fact for a few years. So he remodeled his real estate brokerage into something completely new to solve the problem for his jet-setting international client base.
Ryan Early, hailed as 'Farmer Ryan' among sustainable agriculture experts, is a busy man. He has a laundry list of companies to his name, including Blue-Green Ventures, the company behind the revolutionary product, Blue MagicTM, a non-toxic and eco-sustainable pest preventative product using his patented BiomeMax TM Pheromonal Replication Technology.
Investor, financier, and expert in both cryptocurrencies and blockchain technology, Joy Mbanugo is the go-to in the sector. She has vast experience and knowledge across tax services, auditing, business operations, financial analysis, capital markets, and other specializations.
When Nick Collins was just 14 years old, he started his first business, which included around-the-clock phone calls and numerous questions from his parents. In fact, he began building his stout portfolio in the seventh grade by doing web design, incorporating creative content with brand strategies and plugging in a then-fledgling tech Flash.
Barry Gabster is the founder of InitiateU and is a leading proponent of the marketing mailer revolution, having already taken his company to 10x growth in 2021, alone. In fact, the exponential growth has seen the company rise from $800K-$8.5M just on word-of-mouth referrals.